Advertisement
Screener

Raptor Pharmaceutical Corp Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

Raptor Pharmaceutical Corp Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

Raptor Pharmaceutical Corp reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $1.21 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-26.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2016-02-26

  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-12-31 was $0.00.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-09-30 was $0.00.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-06-30 was $1.21M.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2015 was $1.21M, a 83.93% decline from fiscal 2014.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2014 was $7.50M, a 62.65% decline from fiscal 2013.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2013 was $20.09M.
  • Raptor Pharmaceutical Corp fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2012 was $9.48M.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 4 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$0.00
derived: sum of 2 quarters · filed 2016-02-26
$1.21M
derived: sum of 3 quarters · filed 2016-02-26
$1.21M
10-K · filed 2016-02-26
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$1.21M
derived: sum of 2 quarters · filed 2015-11-05
$1.21M
10-Q · filed 2015-11-05
$1.21M
derived: sum of 4 quarters · filed 2016-02-26
2015-06-30$1.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$1.21M
10-Q · filed 2015-08-06
$1.21M
derived: sum of 3 quarters · filed 2016-02-26
$1.21M
derived: sum of 4 quarters · filed 2016-02-26
2015-03-31$0.00
10-Q · filed 2015-05-07
$0.00
derived: sum of 2 quarters · filed 2016-02-26
$0.00
derived: sum of 3 quarters · filed 2016-02-26
$0.00
derived: sum of 4 quarters · filed 2016-02-26
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$0.00
derived: sum of 2 quarters · filed 2016-02-26
$0.00
derived: sum of 3 quarters · filed 2016-02-26
$7.50M
10-K · filed 2016-02-26
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$0.00
derived: sum of 2 quarters · filed 2015-11-05
$7.50M
10-Q · filed 2015-11-05
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$7.50M
10-Q · filed 2015-08-06
2014-03-31$7.50M
10-Q · filed 2015-05-07
2013-12-31$20.09M
10-K · filed 2016-02-26
2012-12-31$2.35M
10-K · filed 2015-03-02
2012-08-31$9.48M
10-K · filed 2015-03-02